Competition and Consolidation in Healthcare | FTC Chair Lina Khan

In this episode, we sit down with one of the most influential figures in government today: Federal Trade Commission Chair Lina Khan. As the youngest FTC chair to ever be appointed, during her tenure the FTC has pushed to ban non-compete agreements, filed lawsuits against healthcare companies engaging in anti-competitive practices, and strengthened the Health Breach Notification Rule (HBNR) to protect sensitive health data.We cover:The FTC's role in healthcare and how it compares to other sectorsThe impact of consolidation and vertical integration in the healthcare industryThe agency's efforts to combat rising drug prices, including the recent actions against major PBMsThe controversial "Orange Book" patent challenges and their implications for drug innovationThe nationwide ban on non-compete agreements and its potential effects on doctorsChair Khan's vision for the future of competition law and its application to healthcareSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.